Pfizer's "fake drug" ads did not breach code

28 April 2009

The UK Advertising Standards Authority has ruled that US drug giant Pfizer's groundbreaking cinema advertising, in which a man is seen  coughing-up a dead rat, did not breach the industry code (Marketletter  February 26). The advert, seen by cinema audiences across the UK,  highlights the danger of obtaining medicines from unregulated sources.  Evidence shows there is a risk of these medicines being counterfeit,  containing too little, too much or no active ingredient, or worse, toxic  substances such as rat poison, boric acid or lead paint.

The ASA investigated the advert after 63 complaints from the public. The  view concludes that the aim of the advert justified the use of  hard-hitting imagery and that it did not cause fear or distress without  good reason, and was unlikely to cause serious or widespread offence.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight